Acorda Therapeutics (30)

Browse by Contract Category

Contracts

Employment letter agreement, dated June 2, 2022, by and between the Registrant and Neil S. Belloff (Filed With SEC on August 9, 2022)
Second Amendment to Manufacturing Services Agreement dated as of December 31, 2021, by and between the Registrant and Catalent Massachusetts, LLC (Filed With SEC on March 18, 2022)
Form of stock option certificate under the Acorda Therapeutics 2016 Inducement Plan (Filed With SEC on March 18, 2022)
Acorda Therapeutics 2016 Inducement Plan (Filed With SEC on March 18, 2022)
Employment letter agreement, dated June 2, 2022, by and between the Registrant and Michael Gesser (Filed With SEC on August 9, 2022)
Amended and restated employment letter agreement, dated June 2, 2022, by and between the Registrant and Kerry Clem (Filed With SEC on August 9, 2022)
Amended and restated employment letter agreement, dated June 2, 2022, by and between the Registrant and Lauren Sabella (Filed With SEC on August 9, 2022)
First Amendment to Manufacturing Services Agreement dated as of October 28, 2021, by and between the Registrant and Catalent Massachusetts, LLC (Filed With SEC on March 18, 2022)
Employment offer letter, dated November 4, 2021, by and between the Registrant and Neil Belloff (Filed With SEC on March 18, 2022)
Employment offer letter, dated November 4, 2021, by and between the Registrant and Michael Gesser (Filed With SEC on March 18, 2022)
Master Consulting Agreement, dated as of January 1, 2022, and Schedule #1 under the Master Consulting Agreement, by and between the Registrant and Burkhard Blank, M.D (Filed With SEC on March 18, 2022)
Separation Agreement and General Release dated December 31, 2021, by and between the Registrant and Burkhard Blank, M.D (Filed With SEC on March 18, 2022)
Amendment dated January 6, 2022, to June 8, 2015 Employment Agreement by and between the Registrant and Lauren Sabella (Filed With SEC on March 18, 2022)
Employment Agreement dated September 1, 2020, by and between the Company and Kerry Clem (Filed With SEC on September 9, 2021)
Acorda Therapeutics, Inc. Directors Compensation Policy, as amended April 15, 2021 (Filed With SEC on May 12, 2021)
Severance policies applicable to Robert Morales, Vice President, Finance and Controller, and interim principal financial and accounting officer (Filed With SEC on May 12, 2021)
Form of time-based vesting Restricted Stock Unit Agreement for awards under the Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan (Filed With SEC on May 12, 2021)
Manufacturing Services Agreement, dated February 10, 2021, between the Registrant and Catalent Massachusetts LLC (Filed With SEC on March 16, 2021)
Asset Purchase Agreement, dated as of January 12, 2021, between the Registrant and Catalent Pharma Solutions, Inc (Filed With SEC on March 16, 2021)
Description of Common Stock (Filed With SEC on March 16, 2021)
Specimen stock certificate evidencing shares of common stock (Filed With SEC on March 16, 2021)
At The Market Offering Agreement, dated January 13, 2021, between Acorda Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 13, 2021)
Consulting Agreement, dated November 11, 2019, by and between the Registrant and Jane Wasman (Filed With SEC on February 28, 2020)
Description of Common Stock (Filed With SEC on February 28, 2020)
Indenture, dated as of December 23, 2019, among the Company, the guarantors party thereto, and Wilmington Trust, National Association, as trustee and collateral agent (Filed With SEC on December 26, 2019)
Registration Rights Agreement, dated as of December 20, 2019, among the Company and the investors party thereto (Filed With SEC on December 26, 2019)
Security Agreement, dated as of December 23, 2019, from the grantors named therein to Wilmington Trust, National Association, as collateral agent (Filed With SEC on December 26, 2019)
Form of Exchange Agent Agreement, dated as of December 20, 2019, among the Company, the guarantors party thereto, and the holder named therein (Filed With SEC on December 26, 2019)
Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and Jane Wasman (Filed With SEC on November 7, 2019)
Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and David Lawrence (Filed With SEC on November 7, 2019)